Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cervera

Showing results (311-320 of 328) with videos related to

Pageof 33
Sort By:
Annals of the Rheumatic Diseases|April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpointsG K Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|January 22, 2009
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamideF A Houssiau, C Vasconcelos, D D'Cruz, et al.
Medicine|November 13, 2001
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patientsR A Asherson, R Cervera, J C Piette, et al.
Annals of the Rheumatic Diseases|April 5, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosusC Gordon, G Bertsias, J P A Ioannidis, et al.
Annals of the Rheumatic Diseases|November 7, 2009
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studiesM Mosca, C Tani, M Aringer, et al.
Annals of the Rheumatic Diseases|July 27, 2016
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndromeL Andreoli, G K Bertsias, N Agmon-Levin, et al.
Lupus|August 12, 2016
Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre studyO Amengual, R Forastiero, M Sugiura-Ogasawara, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 18, 2018
Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective studyG R de Jesús, S Sciascia, D Andrade, et al.
Annals of the Rheumatic Diseases|August 21, 2010
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairsG K Bertsias, J P A Ioannidis, M Aringer, et al.
Lupus|February 14, 2009
European consensus statement on the terminology used in the management of lupus glomerulonephritisC Gordon, D Jayne, C Pusey, et al.
Pageof 33

Showing results (311-320 of 328) with videos related to

Sort By:
Pageof 33
Annals of the Rheumatic Diseases|April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpointsG K Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|January 22, 2009
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamideF A Houssiau, C Vasconcelos, D D'Cruz, et al.
Medicine|November 13, 2001
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patientsR A Asherson, R Cervera, J C Piette, et al.
Annals of the Rheumatic Diseases|April 5, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosusC Gordon, G Bertsias, J P A Ioannidis, et al.
Annals of the Rheumatic Diseases|November 7, 2009
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studiesM Mosca, C Tani, M Aringer, et al.
Annals of the Rheumatic Diseases|July 27, 2016
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndromeL Andreoli, G K Bertsias, N Agmon-Levin, et al.
Lupus|August 12, 2016
Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre studyO Amengual, R Forastiero, M Sugiura-Ogasawara, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 18, 2018
Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective studyG R de Jesús, S Sciascia, D Andrade, et al.
Annals of the Rheumatic Diseases|August 21, 2010
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairsG K Bertsias, J P A Ioannidis, M Aringer, et al.
Lupus|February 14, 2009
European consensus statement on the terminology used in the management of lupus glomerulonephritisC Gordon, D Jayne, C Pusey, et al.
Pageof 33